More than 8.5%, and it can be opened for up to half a year. At the same time, Dr. Li Hongyuan said that according to the calculation data of the Diabetes Society and medical economics experts, if the incretin payment standard can be revised down from 8.5% of glycosylated hemoglobin to 7.5%, although the cost of medicines will increase in the short term, but in the first From three years onwards, due to the reduction of major cardiovascular and renal complications, the health insurance expenditure can be reduced by about 23 million points, which is equivalent to the sum of the increased drug expenditure in the previous two years; and about 68 million and 68 million yuan can be saved in the fourth and fifth years respectively.
At 124 million points, in the long run, the expected old picture restoration reduction in health care spending will be considerable. In conclusion, if the relevant units have the opportunity to relax the payment standard in the future and help people with diabetes to use incretin intervention therapy as soon as possible, it will not only help save health insurance costs, but also have the benefits of organ protection and lower mortality for people with diabetes.
A win-win situation that benefits society. you may also like Stay away from the three myths about insulin, actively control sugar and replenish insulin as soon as possible Three major diabetes groups join hands with Lions to celebrate the 100th anniversary of insulin and invite famous doctors and sugar friends to color their lives The National Health Insurance Administration relaxes the payment of drug health insurance: Alzheimer's disease, adult ADHD patients will benefit, and more than 16,000 people are expected to benefit Physician's graphic